Saloumeh K Fischer

Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials

Nicola A. Hanania, Phillip E. Korenblat, Kenneth R. Chapman et al. · The Lancet Respiratory Medicine · 2016 · 463 citations

Asthma, Rheumatology, Allergy +10

Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies

Nicola A. Hanania, Michael Noonan, Jonathan Corren et al. · Thorax · 2015 · 374 citations · Full text

Specific Immune Response to Phospholipase B-Like 2 Protein, a Host Cell Impurity in Lebrikizumab Clinical Material

Saloumeh K Fischer, Melissa Cheu, Kun Peng et al. · The AAPS Journal · 2016 · 112 citations

Inflammation, Host Response, Autoimmune Disease +13

Establishment of Neurofilament Light Chain Simoa Assay in Cerebrospinal Fluid and Blood

Robert L. Hendricks, Dana Baker, Jochen Brumm et al. · Bioanalysis · 2019 · 95 citations

Evaluating the Use of Antibody Variable Region (Fv) Charge as a Risk Assessment Tool for Predicting Typical Cynomolgus Monkey Pharmacokinetics

Daniela Bumbaca Yadav, Vikas Sharma, C. Andrew Boswell et al. · Journal of Biological Chemistry · 2015 · 83 citations · Full text